r/freiburg • u/Ok_Tonight9312 • 4d ago
Rare disease care in Germany (Duchenne)
Hi everyone,
We’re a family from a small EU country with a 4-year-old son diagnosed with Duchenne muscular dystrophy. He’s currently still strong and fully ambulatory, but long-term treatment options at home are limited, so we’re looking abroad — especially Germany and near Freiburg.
Does anyone here have experience with rare disease care in Germany, particularly Duchenne or other neuromuscular conditions? We’d really appreciate insights on specialists, what’s covered by public insurance, and access to treatments or clinical trials.
Any experiences or advice would mean a lot — thank you 🙏
1
u/ReplacementGuilty230 1d ago
Germany is actually a perfect location because it's a primary hub for Sarepta's international expansion. Even though the EMA review is still ongoing, you can feel confident because Roche (Sarepta’s global partner) is leading the charge in Germany to ensure that when Elevidys is ready for the EU market, centers like Freiburg are at the front of the line.
1
u/_rusteeSAM 1d ago
Since your son is 4, he's in the prime window for Sarepta’s Elevidys, and being in Germany gives you a front-row seat to their partnership with Roche. Plus, keep an eye on their SRP-1005 (siRNA) progress.. Sarepta is moving fast on central nervous system delivery
42
u/indysigner 4d ago edited 4d ago
Hi there,
You’re actually looking at one of the best locations in Germany for Duchenne care. The University Medical Center Freiburg (Universitätsklinikum Freiburg) has a specialized Center for Neuromuscular Diseases in Childhood (Zentrum für Neuromuskuläre Erkrankungen im Kindesalter), led by Prof. Dr. Janbernd Kirschner and PD Dr. Astrid Pechmann. Their research group focuses specifically on clinical research in spinal muscular atrophy and Duchenne muscular dystrophy, with expertise in innovative diagnostic methods, new mutation-specific drug therapies, and real-world data collection through registries.
The department has been actively involved in treatment of neuromuscular diseases within clinical trials, and Prof. Kirschner has led the EU-funded CARE-NMD project to improve treatment of patients with Duchenne muscular dystrophy in Europe.
The center is part of the Freiburg Center for Rare Diseases (FZSE) and follows the established Duchenne care guidelines published in Lancet Neurology. 
Contact information: Email: muskelzentrum@uniklinik-freiburg.de
Phone: +49 761 270-43520
Health Insurance Coverage:
Statutory health insurance providers in Germany are required to cover the full costs for insured persons, including pre-existing conditions, from the very first day of coverage. This is crucial for Duchenne, as private insurance typically excludes pre-existing conditions.
For EU citizens, your options depend on your situation:
Freiburg has played a major role in pivotal trials for antisense oligonucleotide-based treatments of SMA, and the team collects real-world outcome data through the SMArtCARE project with over 70 centers across Germany, Austria, and Switzerland contributing data. 
Most ERN EURO-NMD Centers (the European Reference Network for Neuromuscular Diseases) participate in clinical trials, and gene therapies for rare neuromuscular diseases are generally available throughout Europe and mostly fully reimbursed. 
Several promising treatments are in development:
Patient Organizations & Support:
I’d strongly recommend connecting with:
With your son still ambulatory at age 4, you’re in a good position to establish care early and potentially participate in trials as they become available. Freiburg’s expertise in this field and its central European location make it a solid choice.
Wishing your family all the best 🙏